This position is contingent upon the modification of the current RMT contract and the award of Option Year Three (3). The projected start date is 3 August 2026. Since 2002 MAT has been providing top-quality services
As a result of the combination of the BD Biosciences and Diagnostic Solutions business with Waters Corporation (NYSE: WAT), by applying to this role, you will be applying for a position with Waters. Waters is a